As of 2024-12-15, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (22.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.76 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -3115.7%.
The range of the Relative Valuation is (19.60) - (25.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 27.1x | 24.0x |
| Forward P/E multiples | 20.9x - 27.5x | 24.9x |
| Fair Price | (19.60) - (25.45) | (22.95) |
| Upside | -2675.4% - -3445.0% | -3115.7% |
| Date | P/E |
| 2024-12-10 | -0.98 |
| 2024-12-09 | -1.01 |
| 2024-12-06 | -1.08 |
| 2024-12-05 | -1.13 |
| 2024-12-04 | -1.27 |
| 2024-12-03 | -1.26 |
| 2024-12-02 | -1.36 |
| 2024-11-29 | -1.36 |
| 2024-11-27 | -1.32 |
| 2024-11-26 | -1.18 |
| 2024-11-25 | -1.06 |
| 2024-11-22 | -1.06 |
| 2024-11-21 | -1.05 |
| 2024-11-20 | -0.95 |
| 2024-11-19 | -0.95 |
| 2024-11-18 | -0.95 |
| 2024-11-15 | -0.89 |
| 2024-11-14 | -0.92 |
| 2024-11-13 | -0.90 |
| 2024-11-12 | -0.98 |
| 2024-11-11 | -1.02 |
| 2024-11-08 | -0.88 |
| 2024-11-07 | -0.75 |
| 2024-11-06 | -0.80 |
| 2024-11-05 | -0.85 |
| 2024-11-04 | -1.52 |
| 2024-11-01 | -1.63 |
| 2024-10-31 | -1.49 |
| 2024-10-30 | -1.70 |
| 2024-10-29 | -1.79 |
| 2024-10-28 | -1.66 |
| 2024-10-25 | -1.61 |
| 2024-10-24 | -1.60 |
| 2024-10-23 | -1.61 |
| 2024-10-22 | -1.69 |
| 2024-10-21 | -1.67 |
| 2024-10-18 | -1.70 |
| 2024-10-17 | -1.56 |
| 2024-10-16 | -1.61 |
| 2024-10-15 | -1.48 |
| 2024-10-14 | -1.51 |
| 2024-10-11 | -1.43 |
| 2024-10-10 | -1.37 |
| 2024-10-09 | -1.36 |
| 2024-10-08 | -1.36 |
| 2024-10-07 | -1.43 |
| 2024-10-04 | -1.40 |
| 2024-10-03 | -1.55 |
| 2024-10-02 | -1.18 |
| 2024-10-01 | -1.46 |